Howard H. Feldman
Division of Neurology
University of British Columbia
UBCH Clinic for Alzheimer's Disease and Related Disorders
Vancouver
Canada
Name/email consistency: high
- Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe. Feldman, H.H., Doody, R.S., Kivipelto, M., Sparks, D.L., Waters, D.D., Jones, R.W., Schwam, E., Schindler, R., Hey-Hadavi, J., DeMicco, D.A., Breazna, A. Neurology (2010)
- Analyses of mortality risk in patients with dementia treated with galantamine. Feldman, H.H., Pirttila, T., Dartigues, J.F., Everitt, B., Van Baelen, B., Brashear, H.R., Berlin, J.A., Battisti, W.P., Kavanagh, S. Acta Neurol. Scand. (2009)
- Treatment with galantamine and time to nursing home placement in Alzheimer's disease patients with and without cerebrovascular disease. Feldman, H.H., Pirttila, T., Dartigues, J.F., Everitt, B., Van Baelen, B., Schwalen, S., Kavanagh, S. Int. J. Geriatr. Psychiatry (2009)
- Predicting response to acetylcholinesterase inhibitor treatment in Alzheimer disease: has the time come? Feldman, H.H., Jacova, C. Nat. Clin. Pract. Neurol (2009)
- Diagnosis and treatment of dementia: 2. Diagnosis. Feldman, H.H., Jacova, C., Robillard, A., Garcia, A., Chow, T., Borrie, M., Schipper, H.M., Blair, M., Kertesz, A., Chertkow, H. CMAJ (2008)
- Rivastigmine: a placebo controlled trial of twice daily and three times daily regimens in patients with Alzheimer's disease. Feldman, H.H., Lane, R. J. Neurol. Neurosurg. Psychiatr. (2007)
- Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study. Feldman, H.H., Ferris, S., Winblad, B., Sfikas, N., Mancione, L., He, Y., Tekin, S., Burns, A., Cummings, J., del Ser, T., Inzitari, D., Orgogozo, J.M., Sauer, H., Scheltens, P., Scarpini, E., Herrmann, N., Farlow, M., Potkin, S., Charles, H.C., Fox, N.C., Lane, R. Lancet. Neurol (2007)
- Activities of daily living in moderate-to-severe Alzheimer disease: an analysis of the treatment effects of memantine in patients receiving stable donepezil treatment. Feldman, H.H., Schmitt, F.A., Olin, J.T. Alzheimer. Dis. Assoc. Disord (2006)
- Cognition, function, and caregiving time patterns in patients with mild-to-moderate Alzheimer disease: a 12-month analysis. Feldman, H.H., Van Baelen, B., Kavanagh, S.M., Torfs, K.E. Alzheimer. Dis. Assoc. Disord (2005)
- Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial. Feldman, H., Gauthier, S., Hecker, J., Vellas, B., Xu, Y., Ieni, J.R., Schwam, E.M. Int. J. Geriatr. Psychiatry (2005)
- Mild cognitive impairment. Feldman, H.H., Jacova, C. Am. J. Geriatr. Psychiatry (2005)
- Behavioral symptoms in mild cognitive impairment. Feldman, H., Scheltens, P., Scarpini, E., Hermann, N., Mesenbrink, P., Mancione, L., Tekin, S., Lane, R., Ferris, S. Neurology (2004)
- Economic evaluation of donepezil in moderate to severe Alzheimer disease. Feldman, H., Gauthier, S., Hecker, J., Vellas, B., Hux, M., Xu, Y., Schwam, E.M., Shah, S., Mastey, V. Neurology (2004)
- Efficacy of donepezil on maintenance of activities of daily living in patients with moderate to severe Alzheimer's disease and the effect on caregiver burden. Feldman, H., Gauthier, S., Hecker, J., Vellas, B., Emir, B., Mastey, V., Subbiah, P. J. Am. Geriatr. Soc (2003)
- A Canadian cohort study of cognitive impairment and related dementias (ACCORD): study methods and baseline results. Feldman, H., Levy, A.R., Hsiung, G.Y., Peters, K.R., Donald, A., Black, S.E., Bouchard, R.W., Gauthier, S.G., Guzman, D.A., Hogan, D.B., Kertesz, A., Rockwood, K. Neuroepidemiology (2003)
- A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease. Feldman, H., Gauthier, S., Hecker, J., Vellas, B., Subbiah, P., Whalen, E. Neurology (2001)
